Share this article
Share this article
NEW YORK, May 20, 2021 /PRNewswire/ Belong.Life, developer of social and professional networks for managing and navigating diseases, and the creator of the world s largest social network for cancer patients, today announced that the American Society of Clinical Oncology (ASCO) has published two abstracts in its 2021 Annual Meeting Abstract Book based on data aggregated from the
Belong Beating Cancer Together app. The abstracts provide key insights into significant challenges for oncology patients, including sexuality and clinical trial participation. Belong.Life strives to provide true value for the global cancer community through our quality real-world data and advanced technology – for patients, caregivers, health professionals, providers and pharma, said Belong.Life CEO Eliran Malki. We are deeply committed to helping advance the state of cancer research, and our AI capabilities offer great understanding into patient journeys, pr
New London-Spicer softball has a strong core yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Nerivio® Wearable Migraine Therapeutic Now Eligible for Insurance Coverage through UpScript s Telemedicine Platform
USA - English
News provided by
Share this article
Share this article
MONTCLAIR, N.J., April 12, 2021 /PRNewswire/ Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that its FDA-authorized Nerivio® prescribed wearable for the acute treatment of migraine is now eligible for insurance coverage through the UpScript direct-to-patient telemedicine platform. It is our mission to make Nerivio accessible to everyone who experiences migraine episodes, said Theranica CEO Alon Ironi. We appreciate the efforts UpScript made to make Nerivio available and covered through its advanced telemedicine platform. People with migraine need rapid, affordable access to safe and effective therapies, and this is exactly what they can get using UpScript. This service connects any patient wi
New Peer-Reviewed Clinical Study Demonstrates Promising Results for Treatment of Partial Thickness Wounds with Nanomedic s Spincare System prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
MONTCLAIR, N.J., March 2, 2021 /PRNewswire/ Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced it has seen consistent growth in the usage of Nerivio, marking more than 100,000 treatments in the USA. We are at a crossroads for acute migraine treatment, where traditional drug-based solutions are being challenged by FDA-authorized, novel digital therapeutics such as Nerivio, said Ronen Jashek, co-founder and COO of Theranica. We are pleased to see that Nerivio patients are showing both adherence to the treatment program and an increased level of comfort with the device itself. 100,000 treatments hold significance to Theranica, as does our recent 33% growth in monthly active users, because these numbers demonstrate that Nerivio users consistently see the benefits of this prescribed therapy to their well-being.